| 注册
首页|期刊导航|医药与保健|常规抗痨方案联合康复新液治疗肺结核的疗效观察

常规抗痨方案联合康复新液治疗肺结核的疗效观察

刘波

医药与保健Issue(4):2-2,8,2.
医药与保健Issue(4):2-2,8,2.

常规抗痨方案联合康复新液治疗肺结核的疗效观察

Observation of curative effect of pulmonary tuberculosis anti tuberculosis therapy combined with Kangfuxin Liquid

刘波1

作者信息

  • 1. 410004湖南省长沙市中心医院肺科二病室
  • 折叠

摘要

Abstract

Objective To discuss the difference between the standard chemotherapy combined with Kangfuxin Liquid and the only standard therapy to treat pulmonary tuberculosis,especially in improving the rate of the sputum becoming negative and the cavity closure rate of cavitary tuberculosis patients. Methods Between January 2010 and December 2012, 120 smear positive patients (cavitary patients included) were divided into two groups at random:experiment group (group A) treated with standard chemotherapy and Kangfuxin;and control group (group B) treated with standard chemotherapy only. Results The sputum of patients becomes negative more quickly, and the rate of cavity occlusion was significantly higher in group A. And also the hemostasis was faster. Conclusion Standard chemotherapy combined with Kangfuxin Liquid is a more effective way for the treatment of the inanition of pulmonary tuberculosis and can reduce the time of becoming negative, worthy of clinical application.

关键词

康复新液/肺结核/空洞/咯血

Key words

Kangfuxin Liquid/Pulmonary tuberculosis/Cavity/Hemoptysis

分类

医药卫生

引用本文复制引用

刘波..常规抗痨方案联合康复新液治疗肺结核的疗效观察[J].医药与保健,2015,(4):2-2,8,2.

医药与保健

2096-1278

访问量0
|
下载量0
段落导航相关论文